Dostarlimab 500mg/10ml solution for infusion vials
NHS hospitals in England used £74,192,133 of indicative cost of Dostarlimab 500mg/10ml solution for infusion vials in the 12 months to April 2026, about 0.3% of all hospital medicines spend. That is up 220.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Dostarlimab 500mg/10ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Dostarlimab 500mg/10ml solution for infusion vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £39,662,942 |
| The Clatterbridge Cancer Centre Nhs Ft | £3,190,933 |
| Imperial College Healthcare Nhs Trust | £2,354,932 |
| Guy's & St Thomas' Nhs Foundation Trust | £1,660,227 |
| University College London Foundation Tr | £1,654,340 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,589,579 |
| The Royal Marsden Nhs Foundation Trust | £1,483,607 |
| Derby Teaching Hospitals Nhs Found Trust | £900,761 |
| Maidstone And Tunbridge Wells Nhs Trust | £753,578 |
| Univ Hpls Bristol Nhs Foundation Trust | £747,691 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.